BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv6.5.5//EN
X-ORIGINAL-URL:https://fokuspatient.se/
X-WR-CALNAME:Fokus Patient
X-WR-CALDESC:- Alltid patienten i fokus
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
DTSTART;TZID=Europe/Stockholm:20201211T130000
DTEND;TZID=Europe/Stockholm:20201211T163000
DTSTAMP:20201201T183100
UID:MEC-2bce32ed409f5ebcee2a7b417ad9beed@fokuspatient.se
CREATED:20201201
LAST-MODIFIED:20201201
PRIORITY:5
TRANSP:OPAQUE
SUMMARY:Public stakeholder meeting: development and authorisation of safe and effective COVID-19 vaccines in the EU
DESCRIPTION:EMA is organising this virtual meeting to explain the processes for the development, evaluation, approval and safety monitoring of COVID-19 vaccines ( https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/covid-19-vaccines-development-evaluation-approval-monitoring ) in the EU, including EMA’s specific role, to all interested parties.\nIt will also give the opportunity to the public and stakeholder groups to speak and share their needs, expectations and any concerns, that will be considered by EMA and the European medicines regulatory network in the decision-making process.\nPlease note that some issues of high public interest, such as patient access to COVID-19 vaccines and national vaccination campaigns, lie outside EMA’s remit and will not be covered at this event.\nThis event will be broadcast live.\nThere is no need to register in advance to follow the live broadcast.\nThe broadcast link will be available on the day. Look here:\nhttps://www.ema.europa.eu/en/events/public-stakeholder-meeting-development-authorisation-safe-effective-covid-19-vaccines-eu  ( https://www.ema.europa.eu/en/events/public-stakeholder-meeting-development-authorisation-safe-effective-covid-19-vaccines-eu )\nDuring the meeting, it will be possible to submit comments by email to: covid19-public-event@ema.europa.eu ( mailto:covid19-public-event@ema.europa.eu ). While such comments cannot be addressed directly during the meeting, EMA will consider them in the relevant regulatory decision-making processes.\n
URL:https://fokuspatient.se/events/public-stakeholder-meeting-development-and-authorisation-of-safe-and-effective-covid-19-vaccines-in-the-eu/
ATTACH;FMTTYPE=image/png:https://fokuspatient.se/wp-content/uploads/2020/12/EMA.png
END:VEVENT
END:VCALENDAR